Prosecution Insights
Last updated: April 19, 2026
Application No. 17/966,935

Composition Containing Polyamideimide Precursor or Polyamideimide, and Polyamideimide Film Produced Using the Same

Final Rejection §103
Filed
Oct 17, 2022
Examiner
KAHN, RACHEL
Art Unit
1766
Tech Center
1700 — Chemical & Materials Engineering
Assignee
SK Ie Technology Co. Ltd.
OA Round
2 (Final)
28%
Grant Probability
At Risk
3-4
OA Rounds
3y 9m
To Grant
44%
With Interview

Examiner Intelligence

Grants only 28% of cases
28%
Career Allow Rate
179 granted / 649 resolved
-37.4% vs TC avg
Strong +16% interview lift
Without
With
+15.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
65 currently pending
Career history
714
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
48.5%
+8.5% vs TC avg
§102
15.5%
-24.5% vs TC avg
§112
23.7%
-16.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 649 resolved cases

Office Action

§103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-13 are pending as filed on 10/17/2022. No amendments were submitted with the response filed on 7/21/2025. No new rejections have been made; therefore, this action is properly made final. Any rejections and/or objections made in the previous Office action and not repeated below are hereby withdrawn. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office Action. Claim Rejections - 35 USC § 103 Claim(s) 1-6 and 8-13 stand rejected under 35 U.S.C. 103 as being unpatentable over Kanada et al (KR 2020001994A; English language equivalent US 20240043619A1 cited) in view of Hasegawa et al (US 2015/0011726). The reasons are as previously set forth in the action mailed on 5/14/2025. Claim(s) 7 stands rejected under 35 U.S.C. 103 as being unpatentable over Kanada et al (KR 2020001994A; English language equivalent US 20240043619A1 cited) in view of Hasegawa et al (US 2015/0011726), and further in view of Park et al (US 2018/0044476). The reasons are as previously set forth in the action mailed on 5/14/2025. Claim(s) 1-6 and 8-13 stand rejected under 35 U.S.C. 103 as being unpatentable over Fukuta et al (WO 2022071443A1; Google machine translation cited) in view of Hasegawa et al (US 2015/0011726). The reasons are as previously set forth in the action mailed on 5/14/2025. Claim(s) 7 stands rejected under 35 U.S.C. 103 as being unpatentable over Fukuta et al (WO 2022071443A1; Google machine translation cited) in view of Hasegawa et al (US 2015/0011726), and further in view of Park et al (US 2018/0044476). The reasons are as previously set forth in the action mailed on 5/14/2025. Response to Arguments Applicant's arguments filed 7/21/2025 have been fully considered. Applicant argues (p 3) that one would not be motivated to consult Hasegawa when trying to form a film having a light transmittance of 87.0% or more at 400 to 700 nm because Hasegawa achieves a maximum of 82% light transmittance at 400 nm in their examples. However, the light transmittance property of a film measured at 400 nm differs from the light transmittance property of a film measured over the entire 400 nm to 700 nm wavelength region. Applicant has not provided any reasoning or evidence which explains why a film having a light transmittance of 82% at 400 nm (as taught by Hasegawa) would be expected to have a total light transmittance lower than 87.0% when measured over the entire 400-700 nm wavelength region. Because the percentage of light transmittance depends on the wavelength(s) at which the property is measured, and because the lower light transmittance percentage disclosed by Hasegawa was measured at a single wavelength rather than over an entire wavelength region, Applicant’s argument that there is no motivation to consult Hasegawa when trying to form a film having a total light transmittance of 87.0% or more over the entire 400 nm to 700 nm wavelength region is unpersuasive. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to RACHEL KAHN whose telephone number is (571)270-7346. The examiner can normally be reached Monday to Friday, 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Randy Gulakowski can be reached at 571-272-1302. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /RACHEL KAHN/Primary Examiner, Art Unit 1766
Read full office action

Prosecution Timeline

Oct 17, 2022
Application Filed
May 08, 2025
Non-Final Rejection — §103
Jul 21, 2025
Response Filed
Aug 21, 2025
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12578342
POLYMERIC DYES HAVING A BACKBONE COMPRISING ORGANOPHOSPHATE UNITS
2y 5m to grant Granted Mar 17, 2026
Patent 12552903
CHALCOGENIDE HYBRID ORGANIC/INORGANIC POLYMERS AND METHODS FOR PRODUCING AND USING THE SAME
2y 5m to grant Granted Feb 17, 2026
Patent 12545765
OLIGOMER OR POLYMER, COMPOSITION, USE OF THE OLIGOMER OR POLYMER AND INTERMEDIATE
2y 5m to grant Granted Feb 10, 2026
Patent 12503631
CURABLE SILICONE PRESSURE SENSITIVE ADHESIVE EMULSION AND METHOD FOR ITS PREPARATION
2y 5m to grant Granted Dec 23, 2025
Patent 12497482
METHOD FOR PREPARING AN ELASTOMER FROM A HYDROXYLATED FATTY ACID AND ELASTOMER OBTAINED BY SUCH A METHOD
2y 5m to grant Granted Dec 16, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
28%
Grant Probability
44%
With Interview (+15.9%)
3y 9m
Median Time to Grant
Moderate
PTA Risk
Based on 649 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month